Pharma Bien-Être SA
3.1 FTEPharma Bien-Être reported total assets of €4.88m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026), with 3.1 full-time equivalents.
The score of Pharma Bien-Être shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +251 % Total assets +46 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Bien-Être's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
Pharma Bien-Être's financial analysis
- Solvency23.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Bien-Être
Pharma Bien-Être's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0776.600.905
- VAT number
- BE0776600905
- Peppol
- Registered · 0208:0776600905 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Oct 2021
- Registered office
- 5100 Namur
- Size
- Micro · 3.1 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Bien-Être (SA) has been based in Namur since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 397,140 € and equity of €1.17m; its revenue is not published. With 3.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 23.9%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma Bien-Être
Companies in the same business, of comparable size and area, outside its group.
- Lucoma Activities of holding companies Nandrin · balance sheet €2.51m
- Pharmacie de Marie Retail sale of pharmaceutical products Binche · balance sheet €8.19m
- Fimovar Retail sale of pharmaceutical products Niel · balance sheet €3.53m
- Brafo Retail sale of pharmaceutical products Bruges · balance sheet €3.49m
- DAHO Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet €7.91m
- Apotheek van der Heggen Retail sale of pharmaceutical products Gavere · balance sheet €1.91m
- PharmaOPS.BXL Retail sale of pharmaceutical products Brussels · balance sheet €3.56m
- Apotheekgroep Zele Retail sale of pharmaceutical products Zele · balance sheet €3.55m
Frequently asked questions about Pharma Bien-Être
What is the revenue of Pharma Bien-Être?
Pharma Bien-Être files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Bien-Être?
In Belgium, the VAT number is the company number prefixed with BE: BE0776600905 for Pharma Bien-Être, if the company is VAT-registered. Its company number (CBE) is 0776.600.905.
Where is the registered office of Pharma Bien-Être?
According to the CBE register, the registered office of Pharma Bien-Être is in 5100 Namur.
What is the equity of Pharma Bien-Être?
At the close of the 2025 financial year, the equity of Pharma Bien-Être amounts to 1,167,257 €, a solvency of 23.9% of total assets.
How many people work at Pharma Bien-Être?
3.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma Bien-Être?
The register lists 2 active mandates at Pharma Bien-Être. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Bien-Être
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →